SI-BONE Inc (NAS:SIBN)
$ 13.38 -0.43 (-3.11%) Market Cap: 557.87 Mil Enterprise Value: 444.76 Mil PE Ratio: 0 PB Ratio: 3.37 GF Score: 70/100

SI-BONE Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 01:30PM GMT
Release Date Price: $22.33 (+3.33%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thanks, everyone, for joining us this morning. I'm Andrew Ranieri, one of the medical device analysts here. And it's my pleasure to have SI-BONE with us here today. And from the company, we have CEO, Laura Francis; and CFO, Anshul Maheshwari. Thank you both for being here.

Before we get started, a quick disclosure. But for important disclosures, please go to morganstanley.com/researchdisclosures for any of the disclaimers.

And with that, kind of let's get into discussion.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

And maybe first, going to you Anshul, but just in terms of the revenue guidance that you gave for the back half of the year and third quarter specifically, there might be some confusion around the third quarter guide and the low single-digit quarter-over-quarter decline that's implied. It sounds like you have a lot of momentum coming out of the second quarter into the third quarter, maybe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot